Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20171
20191
20211
20221
20232
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Active, not recruiting4
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Medical University Innsbruck2
Andreas Guenther1
AstraZeneca1
Bristol-Myers Squibb1
Gilead Sciences1
Insmed Incorporated1
Liquidia Technologies, Inc.1
Ludwig Boltzmann Institute for Lung Health1
Medical University of Graz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial15
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Hypertension, Pulmonary2
Idiopathic Pulmonary Fibrosis2
Scleroderma, Diffuse2
Scleroderma, Systemic2
Autoimmune Diseases1
Fibrosis1
Idiopathic Interstitial Pneumonias1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.